ClinicalTrials.Veeva

Menu

Enhanced Prediction Model for Major Adverse Events Following Acute Myocardial Infarction

Zhejiang University logo

Zhejiang University

Status

Not yet enrolling

Conditions

Myocardial Infarction (MI)

Treatments

Procedure: Percutaneous coronary intervention

Study type

Observational

Funder types

Other

Identifiers

NCT07250152
2025-1224

Details and patient eligibility

About

Acute myocardial infarction (AMI) remains a leading cause of mortality worldwide. Although early revascularization has markedly improved short-term outcomes, the incidence of major adverse cardiovascular events after the index event remains unacceptably high, posing a formidable clinical challenge. Contemporary risk-stratification instruments rely predominantly on a restricted set of conventional clinical variables and therefore fail to capture the full spectrum of individual pathophysiological complexity. To overcome these limitations, the present investigation aims to develop a post-AMI prognostic model that integrates comprehensive multimodal data.

Enrollment

1,544 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age ≥18 years old
  2. Presented with myocardial infarction, including NSTEMI and STEMI
  3. Undergoing successful percutaneous coronary intervention.

Exclusion criteria

  1. Subjects who decline protocol-mandated follow-up or withhold informed consent.
  2. Individuals whose expected survival is < 1 year.

Trial design

1,544 participants in 1 patient group

MI group
Description:
Patients who present with myocardial infarction and undergo successful percutaneous coronary intervention will be eligible for enrollment.
Treatment:
Procedure: Percutaneous coronary intervention

Trial contacts and locations

1

Loading...

Central trial contact

Jun Jiang, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems